Search

everythinglearnresearchcommunity

for

Search:↓

Prostate cancer patients need early psychological and sexual support during radiotherapy to improve their quality of life.

The conclusion is that doctors should be careful when prescribing 5α-reductase inhibitors due to possible serious side effects, and they should discuss these risks with patients.

Testosterone can help premenopausal and postmenopausal women with low sexual desire, but its long-term safety is unclear and it's not widely approved for this use.

Testosterone therapy is effective and safe for women with low sexual desire, but it's hard to access.

Adolescent sexual development should focus on positive aspects, including biological, psychological, and contextual factors, and recognize individual differences and the role of pleasure.

The document concludes that Nonclassic Congenital Adrenal Hyperplasia requires personalized treatment plans to manage symptoms and fertility, with glucocorticoids being a common therapy.

Valproic Acid could potentially be used to treat immune-related conditions due to its ability to modify immune cell functions.

No consistent link between genotype and phenotype in 5-α-Reductase type 2 deficiency.

Early adrenal gland maturation in young children can be normal, but other serious conditions should be ruled out first.

Menopausal women have higher androgen levels, which can cause symptoms like facial hair growth and low sexual desire.

Androgens affect many aspects of female health, and more research is needed to understand their roles and treatment potential.

Testosterone Replacement Therapy can improve sexual health in postmenopausal women with low sexual desire, but more research is needed on its long-term effects.

Peripheral treatments showed some improvement in sexual dysfunction, but central symptoms remain challenging.

Finasteride causes reproductive malformations in male rats.

Female pattern hair loss does not significantly affect sexual dysfunction.

Non-hormonal treatments should be used first for sexual dysfunction in postmenopausal breast cancer patients on aromatase inhibitors, with hormones as a second option.

The document sets criteria for diagnosing long-term sexual dysfunctions caused by certain medications.

SSRIs may help manage sexual behavior in dementia patients, but they can cause long-lasting sexual dysfunction.

Buserelin safely and effectively suppresses early puberty, potentially improving final height.

RSPO1 mutations in certain patients lead to skin cells that don't develop properly and are more likely to become invasive, increasing the risk of skin cancer.

Higher early lead exposure is linked to delayed puberty in girls.

Puberty involves complex hormonal changes, varies by gender and ethnicity, and requires careful monitoring for abnormalities.

Recombinant gonadotropins improve future fertility in CHH patients.

Finasteride improves hair but may reduce sperm quality at higher doses.

DHEA may help with sexual function when used intravaginally by menopausal women but is similar to hormone therapy in other aspects and might cause more side effects like acne and hair loss.

Some patients may experience lasting sexual dysfunction, depression, and other side effects from 5α-reductase inhibitor therapy.

Post-finasteride syndrome causes lasting sexual, neurological, and physical side effects in some people after taking finasteride.

Testosterone therapy may slightly improve sexual function in postmenopausal women, but its long-term safety is unknown.

Testosterone therapy can help improve mood, sexual function, and bone health in women with low androgen levels, but more research is needed to establish safe and effective guidelines.

Male hormones and their interactions are crucial for male sexual development and characteristics.